Home/Filings/4/0001493152-23-041501
4//SEC Filing

Goodwin Charles D. II 4

Accession 0001493152-23-041501

CIK 0000719135other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:12 PM ET

Size

5.2 KB

Accession

0001493152-23-041501

Insider Transaction Report

Form 4
Period: 2023-11-14
Goodwin Charles D. II
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-11-14$1.57/sh+50,000$78,50090,000 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at a prices ranging from $1.56 to $1.57. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Documents

1 file

Issuer

Apyx Medical Corp

CIK 0000719135

Entity typeother

Related Parties

1
  • filerCIK 0001726988

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:12 PM ET
Size
5.2 KB